Biotechnology Stocks I Performance Guide: BioCryst Pharmaceuticals, Inc. (BCRX)
BCRX has no dividends.
Table and Chart of BCRX Performance
See what a $1,000 investment in BCRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BCRX Returns | |
|---|---|
| Start Date | Oct-31-2014 |
| Start Price | $11.72 |
| End Date | Oct-11-2024 |
| End Price | $7.43 |
| # Prices | 121 |
| Min Date | Feb-29-2016 |
| Min Price | $1.99 |
| Max Date | Feb-28-2022 |
| Max Price | $16.61 |
| Total Return | -36.60% |
| Annualized Return | -4.42% |
| Current Value of $1,000 Purchase | $634 |
| Number Returns | 7,260 |
| Average Return | 43.00% |
| Number Profitable Returns | 3,877 |
| Percent Profitable Returns | 53.40% |
| Number Unprofitable Returns | 3,383 |
| Percent Unprofitable Returns | 46.60% |
| Profitable to Unprofitable Returns Ratio | 1.15 |
| BCRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -12.200 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -52709000 |
| PE to Growth Ratio | None |
| Price to Book | 4.021 |
| PRICE DATA | |
| 52 Week High | $1.876 |
| 52 Week Low | $8.88 |
| Analyst Target Price | $0.325 |
| 50-Day Moving Average | $4.03 |
| 200-Day Moving Average | $7.79 |
| FINANCIAL DATA | |
| Revenue per Share | $-0.73 |
| Revenue | $-19 |
| Profit Margin | 190.2% |
| Return on Equity | -6.91% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BCRX Compare Returns with S&P 500
BCRX Trendline Chart
BCRX Moving Average Chart
BCRX Stock Return Map - See Patterns of Gains and Losses
BCRX Stock Returns/Purchase Dates